DNMT3A and acute myeloid leukemia: Nevertheless, all these results round off our different computational studies for the TCGA cohort and indicate that the characteristic discriminative gene mutation and expression signatures that distinguished short- from long-lived DNMT3A-mutated TCGA AML patients are also predictive for other independent patient cohorts and potentially useful to improve patient stratification.